Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DULOXETINE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where DULOXETINE was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for DULOXETINE

Side Effect Reports % Deaths Hosp.
Nausea 7,355 14.1% 76 844
Dizziness 6,983 13.4% 48 772
Drug withdrawal syndrome 6,503 12.5% 30 479
Headache 5,541 10.6% 24 606
Fatigue 5,309 10.2% 28 586
Insomnia 5,270 10.1% 37 506
Anxiety 4,973 9.5% 44 620
Paraesthesia 4,854 9.3% 20 380
Drug ineffective 4,829 9.3% 50 599
Hyperhidrosis 4,101 7.9% 29 460
Suicidal ideation 4,014 7.7% 51 611
Off label use 3,711 7.1% 82 615
Agitation 3,630 7.0% 44 445
Irritability 3,554 6.8% 25 304
Diarrhoea 3,330 6.4% 21 450

Other Indications for DULOXETINE

Product used for unknown indication (15,350) Depression (11,681) Pain (3,418) Fibromyalgia (2,876) Anxiety (2,328) Major depression (1,514) Neuralgia (1,480) Back pain (1,003) Neuropathy peripheral (864) Migraine (683)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

DULOXETINE Full Profile All Relapsing-remitting multiple sclerosis Drugs DULOXETINE Demographics DULOXETINE Timeline